Skip to main content
PMC home page
Neurotherapeutics logoLink to Neurotherapeutics
. 2007 Jul;4(3):420–427. doi: 10.1016/j.nurt.2007.05.012

Ultrasound-enhanced thrombolysis in acute ischemic stroke: Potential, failures, and safety

Georgios Tsivgoulis 1, Andrei V Alexandrov 1,✉
PMCID: PMC7479735  PMID: 17599707

Summary

Experimental and pilot clinical evidence shows that thrombolysis with intravenous tissue plasminogen activator (TPA) can be enhanced with ultrasound. Ultrasound delivers mechanical pressure waves to the clot, thus exposing more thrombus surface to circulating drug. The international multi-center phase II CLOTBUST trial showed that, in patients with acute ischemic stroke, transcranial Doppler (TCD) monitoring augments TPA-induced arterial recanalization, with a nonsignificant trend toward an increased rate of recovery from stroke, compared with placebo. In the CLOTBUST trial, the dramatic clinical recovery from stroke coupled with complete recanalization within 2 hours after TPA bolus occurred in 25% of patients treated with TPA + TCD (n = 63), compared with 8% of those who received TPA alone (n = 63, P = 0.02). Different results were achieved in smaller studies that used transcranial color-coded duplex sonography (TCCD) and a nonimaging therapeutic ultrasound system. The findings of the TRUMBI trial (26 patients) underscored the adverse bioeffects of midkilohertz (300 kHz) ultrasound, such as promotion of bleeding in brain areas both affected and unaffected by ischemia. Exposure to multifrequency, multielement duplex ultrasound resulted in a trend toward a higher risk of hemorrhagic transformation. To further enhance the ability of TPA to break up thrombi, current ongoing clinical trials include phase II studies of a single-beam, 2-MHz TCD with perflutren lipid microspheres. Enhancement of intra-arterial TPA delivery is being clinically tested with 1.7–2.1 MHz pulsed-wave ultrasound (EKOS catheter). Multinational dose escalation studies of microspheres and the development of an operator-independent ultrasound device are underway.

Key Words: Tissue plasminogen activator, transcranial Doppler, stroke, thrombolysis, microspheres

References

  • 1.del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78–86. doi: 10.1002/ana.410320113. [DOI] [PubMed] [Google Scholar]
  • 2.Brott TG, Haley EC, Levy DE, et al. Urgent therapy for stroke. Part I. pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23:632–640. doi: 10.1161/01.str.23.5.632. [DOI] [PubMed] [Google Scholar]
  • 3.Haley EC, Levy DE, Brott TG, et al. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset. Stroke. 1992;23:641–645. doi: 10.1161/01.str.23.5.641. [DOI] [PubMed] [Google Scholar]
  • 4.The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1587. doi: 10.1056/NEJM199512143332401. [DOI] [PubMed] [Google Scholar]
  • 5.Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke: the European Cooperative Acute Stroke Study. JAMA. 1995;274:1017–1025. doi: 10.1001/jama.274.13.1017. [DOI] [PubMed] [Google Scholar]
  • 6.Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245–1251. doi: 10.1016/S0140-6736(98)08020-9. [DOI] [PubMed] [Google Scholar]
  • 7.Hacke W, Donnan G, Fieschi C, ATLANTIS Trials Investigators. ECASS Trials Investigators. NINDS rt-PA Study Group Investigators et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768–774. doi: 10.1016/S0140-6736(04)15692-4. [DOI] [PubMed] [Google Scholar]
  • 8.Haley EC, Lewandowski C, Tilley BC. Myths regarding NINDS rt-PA stroke trial: setting the record straight. Ann Emerg Med. 1997;30:676–682. doi: 10.1016/S0196-0644(97)99996-0. [DOI] [PubMed] [Google Scholar]
  • 9.Demchuk AM, Felberg RA, Alexandrov AV. Clinical recovery from acute ischemic stroke after early reperfusion of the brain with intravenous thrombolysis. N Engl J Med. 1999;340:894–895. doi: 10.1056/NEJM199903183401117. [DOI] [PubMed] [Google Scholar]
  • 10.Grotta JC, Alexandrov AV. TPA-associated reperfusion in acute ischemic stroke demonstrated by SPECT. Stroke. 1998;29:429–432. doi: 10.1161/01.str.29.2.429. [DOI] [PubMed] [Google Scholar]
  • 11.Heiss W-D, Grond M, Thiel A, et al. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab. 1998;18:1298–1307. doi: 10.1097/00004647-199812000-00004. [DOI] [PubMed] [Google Scholar]
  • 12.Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology. 1992;42:289–298. doi: 10.1212/wnl.42.2.289. [DOI] [PubMed] [Google Scholar]
  • 13.Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967–973. doi: 10.1161/01.STR.0000258112.14918.24. [DOI] [PubMed] [Google Scholar]
  • 14.Trubestein R, Bernard HR, Etzel F, Sobbe A, Cremer A, Stumpff U. Thrombolysis by ultrasound. Clin Sci Mol Med. 1976;51:697–698. doi: 10.1042/cs051697s. [DOI] [PubMed] [Google Scholar]
  • 15.Tachibana K, Tachibana S. Ultrasonic vibration for boosting fibrinolytic effects of urokinase in vivo [abstract] Thromb Haemost. 1981;46:211–211. [Google Scholar]
  • 16.Lauer CG, Burge R, Tang DB, Bass BG, Gomez ER, Alving BM. Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis. Circulation. 1992;86:1257–1264. doi: 10.1161/01.cir.86.4.1257. [DOI] [PubMed] [Google Scholar]
  • 17.Kimura M, Iijima S, Kobayashi K, Furuhata H. Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasound irradiation: in vitro experiment involving assay of the fibrin degradation products from the clot. Biol Pharm Bull. 1994;17:126–130. doi: 10.1248/bpb.17.126. [DOI] [PubMed] [Google Scholar]
  • 18.Akiyama M, Ishibashi T, Yamada T, Furuhata H. Low-frequency ultrasound penetrates the cranium and enhances thrombolysis in vitro. Neurosurgery. 1998;43:828–832. doi: 10.1097/00006123-199810000-00062. [DOI] [PubMed] [Google Scholar]
  • 19.Suchkova V, Siddiqi FN, Carstensen EL, Dalecki D, Child S, Francis CW. Enhancement of fibrinolysis with 40-kHz ultrasound. Circulation. 1998;98:1030–1035. doi: 10.1161/01.cir.98.10.1030. [DOI] [PubMed] [Google Scholar]
  • 20.Behrens S, Daffertshofer M, Spiegel D, Hennerici M. Low-frequency, low-intensity ultrasound accelerates thrombolysis through the skull. Ultrasound Med Biol. 1999;25:269–273. doi: 10.1016/S0301-5629(98)00158-6. [DOI] [PubMed] [Google Scholar]
  • 21.Polak JF. Ultrasound energy and the dissolution of thrombus. N Engl J Med. 2004;351:2154–2155. doi: 10.1056/NEJMp048249. [DOI] [PubMed] [Google Scholar]
  • 22.Sakharov DV, Barrertt-Bergshoeff M, Hekkenberg RT, Rijken DC. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro. Thromb Haemost. 1999;81:605–612. [PubMed] [Google Scholar]
  • 23.Spengos K, Behrens S, Daffertshofer M, Dempfle CE, Hennerici M. Acceleration of thrombolysis with ultrasound through the cranium in a flow model. Ultrasound Med Biol. 2000;26:889–895. doi: 10.1016/S0301-5629(00)00211-8. [DOI] [PubMed] [Google Scholar]
  • 24.Behrens S, Spengos K, Daffertshofer M, Schroeck H, Dempfle CE, Hennerici M. Transcranial ultrasound-improved thrombolysis: diagnostic vs. therapeutic ultrasound. Ultrasound Med Biol. 2001;27:1683–1689. doi: 10.1016/S0301-5629(01)00481-1. [DOI] [PubMed] [Google Scholar]
  • 25.Blinc A, Francis CW, Trudnowski JL, Carstensen EL. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood. 1993;81:2636–2643. [PubMed] [Google Scholar]
  • 26.Alexandrov AV, Demchuk AM, Felberg RA, et al. High rate of complete recanalization and dramatic clinical recovery during TPA infusion when continuously monitored by 2-MHz transcranial Doppler monitoring. Stroke. 2000;31:610–614. doi: 10.1161/01.str.31.3.610. [DOI] [PubMed] [Google Scholar]
  • 27.Chemyshev OY, Garami Z, Calleja S, et al. The yield and accuracy of urgent combined carotid-transcranial ultrasound testing in acute cerebral ischemia. Stroke. 2005;36:32–37. doi: 10.1161/01.STR.0000150496.27584.e3. [DOI] [PubMed] [Google Scholar]
  • 28.Tsivgoulis G, Sharma VK, Lao AY, Malkoff MD, Alexandrov AV. Validation of transcranial Doppler with computed tomography angiography in acute cerebral ischemia. Stroke. 2007;38:1245–1249. doi: 10.1161/01.STR.0000259712.64772.85. [DOI] [PubMed] [Google Scholar]
  • 29.Kim YS, Meyer JS, Garami Z, Molina CA, Pavlovic AM, Alexandrov AV. Flow diversion in transcranial Doppler ultrasound is associated with better improvement in patients with acute middle cerebral artery occlusion. Cerebrovasc Dis. 2006;21:74–78. doi: 10.1159/000090006. [DOI] [PubMed] [Google Scholar]
  • 30.Kim YS, Garami Z, Mikulik R, Molina CA, Alexandrov AV, CLOTBUST Collaborators Early recanalization rates and clinical outcomes in patients with tandem internal carotid artery/middle cerebral artery occlusion and isolated middle cerebral artery occlusion. Stroke. 2005;36:869–871. doi: 10.1161/01.STR.0000160007.57787.4c. [DOI] [PubMed] [Google Scholar]
  • 31.Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351:2170–2178. doi: 10.1056/NEJMoa041175. [DOI] [PubMed] [Google Scholar]
  • 32.Eggers J, Koch B, Meyer K, Konig I, Scidel G. Effect of ultrasound on thrombolysis of middle cerebral artery occlusion. Ann Neurol. 2003;53:797–800. doi: 10.1002/ana.10590. [DOI] [PubMed] [Google Scholar]
  • 33.Eggers J, Scidel G, Koch B, Konig IR. Sonothrombolysis in acute ischemic stroke for patients ineligible for rt-PA. Neurology. 2005;64:1052–1054. doi: 10.1212/01.WNL.0000154599.45969.D6. [DOI] [PubMed] [Google Scholar]
  • 34.Cintas P, Le Traon AP, Larrue V. High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug. Stroke. 2002;33:626–628. doi: 10.1161/hs0202.103073. [DOI] [PubMed] [Google Scholar]
  • 35.Skoloudik D, Bar M, Hradilek P, Vaclavik D, Skoda O. Safety and efficacy of thrombotripsy: acceleration of thrombolysis by TCCS. In: Proceedings of the NSRG 2003 Meeting, Germany: Karger [CD-ROM].
  • 36.The IMS Study Investigators Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004;35:904–912. doi: 10.1161/01.STR.0000121641.77121.98. [DOI] [PubMed] [Google Scholar]
  • 37.Daffertshofer M, Hennerici M. Ultrasound in the treatment of ischaemic stroke. Lancet Neurol. 2003;2:283–290. doi: 10.1016/S1474-4422(03)00380-6. [DOI] [PubMed] [Google Scholar]
  • 38.Behrens S, Spengos K, Daffertshofer M, Wirth S, Hennerici M. Potential use of therapeutic ultrasound in ischemic stroke treatment. Echocardiography. 2001;18:259–263. doi: 10.1046/j.1540-8175.2001.00259.x. [DOI] [PubMed] [Google Scholar]
  • 39.Daffertshofer M, Gass A, Ringleb P, et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator. Stroke. 2005;36:1441–1446. doi: 10.1161/01.STR.0000170707.86793.1a. [DOI] [PubMed] [Google Scholar]
  • 40.Unger EC, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev. 2004;56:1291–1314. doi: 10.1016/j.addr.2003.12.006. [DOI] [PubMed] [Google Scholar]
  • 41.Culp WC, Porter TR, McCowan TC, et al. Microbubble-augmented ultrasound declotting of thrombosed arteriovenous dialysis grafts in dogs. J Vasc Interv Radiol. 2003;14:343–347. doi: 10.1097/01.rvi.0000058409.01661.b4. [DOI] [PubMed] [Google Scholar]
  • 42.Culp WC, Porter TR, Lowery J, Xie F, Roberson PK, Marky L. Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke. 2004;35:2407–2411. doi: 10.1161/01.STR.0000140890.86779.79. [DOI] [PubMed] [Google Scholar]
  • 43.Molina CA, Ribo M, Rubiera M, et al. Microbubbles administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke. 2006;37:425–429. doi: 10.1161/01.STR.0000199064.94588.39. [DOI] [PubMed] [Google Scholar]
  • 44.Alexandrov AV, Mikulik R, Ribo M, et al. A pilot randomized clinical safety study of thrombolysis augmentation with ultrasound-activated perflutren lipid microspheres. Stroke. 2007;38:LBP4–LBP4. doi: 10.1161/STROKEAHA.107.505727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Perren F, Loulidi J, Poglia D, Landis T, Sztajzel R. Microbubble potentiated tianscranial duplex ultrasound enhances IV thrombolysis in acute stroke. J Thromb Thrombolysis. May 20, 2007 [Epub ahead of print]. [DOI] [PubMed]
  • 46.Larrue V, Viguier A, Amaud C, et al. Tianscranial ultrasound combined with intravenous microbubbles and tissue plasminogen activator for acute ischemic stroke: a randomized controlled study [abstract] Stroke. 2007;38:472–472. [Google Scholar]
  • 47.Sharma VK, Tsivgoulis G, Lao AY, Malkoff MD, Alexandrov AW, Alexandrov AV. Quantification of microbubble appearance in brain vessels: implications for dose calculations and drug delivery [abstract] Stroke. 2007;38:493–493. doi: 10.1161/STROKEAHA.107.490755. [DOI] [PubMed] [Google Scholar]
  • 48.The NINDS t-PA Stroke Study Group Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28:2109–2118. doi: 10.1161/01.str.28.11.2109. [DOI] [PubMed] [Google Scholar]
  • 49.Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) Lancet. 1998;352:1245–1251. doi: 10.1016/S0140-6736(98)08020-9. [DOI] [PubMed] [Google Scholar]
  • 50.Meairs S, Wahlgren N, Dimagl U, et al. Stroke research priorities for the next decade: a representative view of the European scientific community. Cerebrovasc Dis. 2006;22:75–82. doi: 10.1159/000093098. [DOI] [PubMed] [Google Scholar]
  • 51.Alexandrov AV. Ultrasound enhanced thrombolysis for stroke. Int J Stroke. 2006;1:26–29. doi: 10.1111/j.1747-4949.2005.00012.x. [DOI] [PubMed] [Google Scholar]

Articles from Neurotherapeutics are provided here courtesy of Elsevier

RESOURCES